Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2001
09/27/2001WO2001070966A1 A novel polypeptide, a human clathrin light chain 11 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070965A1 A novel polypeptide, a human regulatory transcription factor 15 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070963A1 A novel polypeptide, a human clotting factor ix-10 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070961A1 A novel polypeptide, a human microtubulin folding factor c16 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070960A1 A novel polypeptide, a human dna mismatch repair gene protein 13 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070959A1 A novel polypeptide, a human regulatory transcription factor 10 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070957A1 A novel polypeptide, a human dna mismatch repair protein 9.4 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070956A1 A novel polypeptide, a human dna mismatch repair protein 8 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070954A2 Regulation of human nerve growth factor-elated g protein-coupled receptor
09/27/2001WO2001070953A2 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment
09/27/2001WO2001070952A1 Human gata-5 transcription factor
09/27/2001WO2001070951A2 Agent for the diagnosis and therapy of viral diseases
09/27/2001WO2001070950A2 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion
09/27/2001WO2001070945A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
09/27/2001WO2001070941A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
09/27/2001WO2001070930A2 Growth factor binding molecules
09/27/2001WO2001070816A2 Ecdysone receptor-based inducible gene expression system
09/27/2001WO2001070815A1 Novel leukotriene b4 receptor
09/27/2001WO2001070814A2 Regulation of human rta-like g protein-coupled receptor
09/27/2001WO2001070813A2 REGULATION OF HUMAN GluR5-LIKE RECEPTOR
09/27/2001WO2001070809A1 A novel polypeptide - protein 9 of growth hormone-family and a polynucleotide sequence encoding the same
09/27/2001WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same
09/27/2001WO2001070805A2 Soluble mast cell function associated antigen (mafa) pharmaceutical compositions and methods of making and using them
09/27/2001WO2001070804A1 7 human ovarian and ovarian cancer associated proteins
09/27/2001WO2001070803A1 A novel polypeptide - human regulatory transcription factor 9.7 and a polynucleotide sequence encoding the same
09/27/2001WO2001070802A1 A novel polypeptide, zinc finger protein 11 and the polynucleotide encoding thereof
09/27/2001WO2001070800A1 A novel polypeptide-human atp-dependent helicase protein 11 and a polynucleotide sequence encoding the same
09/27/2001WO2001070799A1 Novel protein having hemolytic activity and gene encoding the protein
09/27/2001WO2001070796A1 A novel polypeptide, a human zinc finger protein 78 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070795A1 A novel polypeptide, a human phosphoribosyl glycinamide synthetase 13 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070793A1 A novel polypeptide, a human mitochondrial carrier protein 9 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070792A1 A novel polypeptide, a human tyrosinase 12 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070791A1 A novel polypeptide, a human nf-e2 relative factor 14 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070789A1 A novel polypeptide-human ribosomal protein s5-17 and the polynucleotide encoding said polypeptide
09/27/2001WO2001070788A1 A novel polypeptide, a protein kinase c-10 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070787A1 A novel polypeptide, a human transglutaminase 12 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070786A1 A novel polypeptide, a human tnfr/ngfr protein containing cytochrome c domain and the polynucleotide encoding the polypeptide
09/27/2001WO2001070785A1 A novel polypeptide, a human atp-dependent serine protein hydrolase 13 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070784A1 A novel polypeptide-human protein 17 containing chromo domain and the polynucleotide encoding said polypeptide
09/27/2001WO2001070783A1 A novel polypeptide-human gamma-cop protein 16 and the polynucleoide encoding said polypeptide
09/27/2001WO2001070782A1 A novel polypeptide-human dihydroorotase 9 and the polynucleotide encoding said polypeptide
09/27/2001WO2001070781A1 A novel polypeptide-human ilf 13 and the polynucleotide encoding said polypeptide
09/27/2001WO2001070780A1 A novel polypeptide-human ribosomal sii protein 12 and the polynucleotide encoding said polypeptide
09/27/2001WO2001070779A1 A novel polypeptide-human cdc4 analogous protein and the polynucleotide encoding said polypeptide
09/27/2001WO2001070776A2 Nimr compositions and their methods of use
09/27/2001WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same
09/27/2001WO2001070772A2 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of an addition salt to an acid
09/27/2001WO2001070769A1 Peptide derivative
09/27/2001WO2001070768A2 Receptor-binding compounds and method for identifying them
09/27/2001WO2001070767A2 Therapeutic anti-melanoma compounds
09/27/2001WO2001070766A2 Therapeutic anti-cytomegalovirus compounds
09/27/2001WO2001070765A1 Receptor-binding compounds and methods for identifying them
09/27/2001WO2001070763A1 Modified blood clotting factors and methods of use
09/27/2001WO2001070754A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors
09/27/2001WO2001070753A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors
09/27/2001WO2001070746A1 Furoisoquinoline derivatives, process for producing the same and use thereof
09/27/2001WO2001070672A2 Compounds and methods to treat alzheimer's disease
09/27/2001WO2001070337A1 Spiropiperidine derivatives as melanocortin receptor agonists
09/27/2001WO2001070288A2 Thermoreversible polymers for delivery and retention of osteoinductive proteins
09/27/2001WO2001070273A1 The use of anticoagulant agents in the extracorporeal treatment of blood
09/27/2001WO2001070263A1 Composition and method for the prevention and/or the treatment of allergy
09/27/2001WO2001070261A1 Sperm factor oscillogenin
09/27/2001WO2001070259A1 Improvements in and relating to digestive/laxative compositions
09/27/2001WO2001070258A1 Pharmaceutical composition of carrier substance for products based on vitamin-e, bromeline and hyaluronidase
09/27/2001WO2001070256A1 A somatotropin composition with improved syringeability
09/27/2001WO2001070255A2 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
09/27/2001WO2001070254A1 Use of human not1 and not1a orphan receptors
09/27/2001WO2001070253A1 Use of mia in immunotherapy
09/27/2001WO2001070247A2 Salmonella vaccine materials and methods
09/27/2001WO2001070244A1 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
09/27/2001WO2001070243A2 A method for treating early breast cancer
09/27/2001WO2001070231A2 Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries
09/27/2001WO2001070203A2 Agent for treating hepatitis c containing ukrain
09/27/2001WO2001070174A2 Vegf-modulated genes and methods employing them
09/27/2001WO2001070173A2 Immunokine composition and method
09/27/2001WO2001070031A1 Opioid growth factor modulates angiogenesis
09/27/2001WO2001032201A3 A pharmaceutical composition having high cell membrane permeability
09/27/2001WO2001025390A3 Water unstable foam compositions
09/27/2001WO2001021802B1 Chlamydia antigens and corresponding dna fragments and uses thereof
09/27/2001WO2001019990B1 Rip-3-like death-associated kinase
09/27/2001WO2001019829A3 Pyrazolopyrimidines as therapeutic agents
09/27/2001WO2001019386A3 Composition for stabilizing corneal tissue during or after orthokeratology lens wear
09/27/2001WO2001019384A3 Ant-1 as drug target
09/27/2001WO2001018546A3 Screening for inhibitors of 'paired helical filaments'
09/27/2001WO2001018030A3 Small peptides having potent anti-angiogenic activity
09/27/2001WO2001017558A3 Novel uses of mammalian ccr6 receptors and related reagents
09/27/2001WO2001017547A3 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons
09/27/2001WO2001016170A3 Card proteins involved in cell death regulation
09/27/2001WO2001012127B1 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
09/27/2001WO2001010903A3 Proteases and protease inhibitors
09/27/2001WO2001009178A3 Human chaperone proteins
09/27/2001WO2001000665A3 Inhibitors of memapsin 2 and use thereof
09/27/2001WO2000071148A3 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
09/27/2001WO2000061541A3 Pharmaceutical compounds
09/27/2001WO2000061537A3 Pharmaceutical compounds
09/27/2001WO2000057837A8 Compositions and methods for effecting the levels of cholesterol
09/27/2001WO2000012047A3 Enhancement of return to independent living status with a growth hormone secretagogue
09/27/2001US20010025099 G protein-coupled receptor polypeptides and polyncleotides
09/27/2001US20010025097 Somatostatins and methods
09/27/2001US20010025059 Use of bioflavonoid comprising quercetin, bromelin and papain for reducing symptomatic effects of chronic prostatis
1 ... 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 ... 3163